CVS:NYE-CVS Health Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 44.22

Change

-0.67 (-1.49)%

Market Cap

USD 78.05B

Volume

0.01B

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-02 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 460.26B
ELV Elevance Health Inc

N/A

USD 88.46B
CNC Centene Corp

N/A

USD 30.08B
MOH Molina Healthcare Inc

N/A

USD 16.86B
OSCR Oscar Health Inc

N/A

USD 3.55B
NEUE NeueHealth Inc

N/A

USD 0.06B
CI Cigna Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CVS

FHI-B:CA CI Health Care Giants Cov.. 5.45 % 0.00 %

N/A

CAD 0.05B
XVTD:LSE Xtrackers - FTSE Vietnam .. 4.04 % 0.00 %

N/A

USD 0.26B
XFVT:SW Xtrackers FTSE Vietnam Sw.. 4.04 % 0.00 %

N/A

USD 0.26B
XFVT:XETRA Xtrackers - FTSE Vietnam .. 4.04 % 0.00 %

N/A

USD 0.35B
UINC:LSE First Trust US Equity Inc.. 2.38 % 0.00 %

N/A

USD 0.31B
UNCU:LSE First Trust US Equity Inc.. 2.37 % 0.00 %

N/A

USD 0.03B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.30 % 0.00 %

N/A

USD 0.14B
VMAX REX VolMAXX Long VIX Futu.. 1.57 % 0.00 %

N/A

USD 0.05B
SHRT Tidal ETF Trust 1.18 % 0.00 %

N/A

USD 0.01B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

N/A

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

N/A

USD 0.08B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

N/A

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

N/A

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

N/A

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.47B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

N/A

USD 0.94B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

N/A

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.05B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

N/A

USD 0.59B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

N/A

N/A
PBI:CA Purpose Best Ideas 0.00 % 0.79 %

N/A

CAD 0.01B
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

N/A

USD 0.99B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

N/A

USD 0.09B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.08B
DWSH AdvisorShares Dorsey Wrig.. 0.00 % 0.00 %

N/A

USD 0.01B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

N/A

USD 2.72B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

N/A

USD 2.43B
RTH VanEck Retail ETF 0.00 % 0.35 %

N/A

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

N/A

USD 2.13B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
STPL:CA BMO Global Consumer Stapl.. 0.00 % 0.40 %

N/A

CAD 0.04B
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

N/A

USD 0.09B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
ZPRU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.13B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA SPDR MSCI USA Value UCITS.. 0.00 % 0.00 %

N/A

USD 0.13B
GBLO 0.00 % 0.00 %

N/A

N/A
LBAY Tidal ETF Trust - Leather.. 0.00 % 0.00 %

N/A

USD 0.03B
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.49% 11% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.49% 11% F 9% A-
Trailing 12 Months  
Capital Gain -45.08% 25% F 4% F
Dividend Return 3.30% 100% F 48% F
Total Return -41.77% 25% F 4% F
Trailing 5 Years  
Capital Gain -39.89% 17% F 14% F
Dividend Return 15.33% 100% F 51% F
Total Return -24.56% 33% F 14% F
Average Annual (5 Year Horizon)  
Capital Gain 1.37% 25% F 38% F
Dividend Return 3.88% 50% F 39% F
Total Return 2.51% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 29.09% 25% F 37% F
Risk Adjusted Return 13.35% 38% F 29% F
Market Capitalization 78.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector